HKSE:01530 (China)
Â
Shs Unitary 144A/Reg S
HK$
6.37
(-1.09%)
May 28
Current and historical daily PE Ratio for 3SBio Inc (
) from 2015 to May 28 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. 3SBio stock (HKSE:01530) PE ratio as of May 28 2024 is 9.38.
More Details
3SBio Inc (HKSE:01530) PE Ratio (TTM) Chart
3SBio Inc (HKSE:01530) PE Ratio (TTM) Historical Data
View and export this data going back to 2015. Start your Free Trial
Total 1213
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| 3SBio PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-28 | 9.4 | 2024-03-19 | 7.9 |
| 2024-05-27 | 9.5 | 2024-03-18 | 8.0 |
| 2024-05-24 | 9.0 | 2024-03-15 | 7.7 |
| 2024-05-23 | 9.2 | 2024-03-14 | 7.8 |
| 2024-05-22 | 9.3 | 2024-03-13 | 7.7 |
| 2024-05-21 | 9.3 | 2024-03-12 | 7.6 |
| 2024-05-20 | 9.5 | 2024-03-11 | 7.4 |
| 2024-05-17 | 9.3 | 2024-03-08 | 7.3 |
| 2024-05-16 | 9.5 | 2024-03-07 | 7.3 |
| 2024-05-14 | 9.7 | 2024-03-06 | 7.6 |
| 2024-05-13 | 9.8 | 2024-03-05 | 7.5 |
| 2024-05-10 | 9.9 | 2024-03-04 | 8.3 |
| 2024-05-09 | 9.9 | 2024-03-01 | 8.3 |
| 2024-05-08 | 9.7 | 2024-02-29 | 7.6 |
| 2024-05-07 | 9.7 | 2024-02-28 | 7.6 |
| 2024-05-06 | 9.7 | 2024-02-27 | 8.0 |
| 2024-05-03 | 10.0 | 2024-02-26 | 7.8 |
| 2024-05-02 | 9.7 | 2024-02-23 | 7.9 |
| 2024-04-30 | 9.3 | 2024-02-22 | 8.0 |
| 2024-04-29 | 9.1 | 2024-02-21 | 8.0 |
| 2024-04-26 | 8.9 | 2024-02-20 | 8.0 |
| 2024-04-25 | 8.9 | 2024-02-19 | 8.1 |
| 2024-04-24 | 8.6 | 2024-02-16 | 8.1 |
| 2024-04-23 | 8.4 | 2024-02-15 | 7.8 |
| 2024-04-22 | 8.2 | 2024-02-14 | 7.8 |
| 2024-04-19 | 8.2 | 2024-02-09 | 8.4 |
| 2024-04-18 | 8.3 | 2024-02-08 | 8.6 |
| 2024-04-17 | 8.2 | 2024-02-07 | 8.6 |
| 2024-04-16 | 8.3 | 2024-02-06 | 8.6 |
| 2024-04-15 | 8.7 | 2024-02-05 | 8.3 |
| 2024-04-12 | 8.8 | 2024-02-02 | 8.6 |
| 2024-04-11 | 8.9 | 2024-02-01 | 8.9 |
| 2024-04-10 | 8.9 | 2024-01-31 | 8.7 |
| 2024-04-09 | 9.2 | 2024-01-30 | 8.6 |
| 2024-04-08 | 8.9 | 2024-01-29 | 8.7 |
| 2024-04-05 | 8.9 | 2024-01-26 | 8.7 |
| 2024-04-03 | 8.9 | 2024-01-25 | 8.9 |
| 2024-04-02 | 8.9 | 2024-01-24 | 8.9 |
| 2024-03-28 | 8.8 | 2024-01-23 | 8.7 |
| 2024-03-27 | 8.4 | 2024-01-22 | 8.4 |
| 2024-03-26 | 8.7 | 2024-01-19 | 8.8 |
| 2024-03-25 | 8.8 | 2024-01-18 | 9.4 |
| 2024-03-22 | 8.8 | 2024-01-17 | 9.2 |
| 2024-03-21 | 8.0 | 2024-01-16 | 9.6 |
| 2024-03-20 | 8.1 | 2024-01-15 | 9.7 |
3SBio Inc (HKSE:01530) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
3SBio Inc
NAICS : 325412
SIC : 2834
ISIN : KYG8875G1029
Share Class Description:
HKSE:01530: Shs Unitary 144A/Reg SCompare
Compare
Traded in other countries / regions
01530.Hong Kong83B.GermanyTRSBF.USA IPO Date
2015-06-11Description
3SBio Inc, or 3SBio is a biotechnology company. As a pioneer in the Chinese biotechnology industry, the Group has extensive expertise in researching, developing, manufacturing, and marketing biopharmaceuticals. The core products of the Group include several biopharmaceutical drugs, TPIAO recombinant human erythropoietin rhEPO products EPIAO and SEPO, Yisaipu, Cipterbin, and a small molecule drug, Mandi. Except for minoxidil, an over-the-counter drug, the others are all older-generation biologics. The majority of its pipeline candidates are "me-too" drugs and in general, are still at an early stage.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers